Fairchem Organics
- P/E
- 36.11
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 3.33%
- Debt to Equity
- 0.25
- EPS (TTM)
- ₹18.87
- Book Value
- ₹223.74
- Market Cap
- —
- P/E (TTM)
- 36.11
- P/B
- 3.05
- ROE
- 2.19%
- Dividend Yield
- 0.15%
- EBITDA
- ₹22.90 Cr
- 52W High
- ₹846.80
- 52W Low
- ₹428.05
- Day Range
- ₹651.00 – ₹687.40
- Volume
- 9,013
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹681.45 | 36.11 | ₹829 Cr | 3.05 | 0.15% | 2.19% | 3.33% | ₹560 Cr | ₹24 Cr | |
| Median 8 companies | ₹1,559.55 | 46.57 | ₹20,474 Cr | 4.68 | 0.19% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 67
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 29
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 67
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 53
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 53
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 37
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Stock is trading at 3.41 times its book value
- The company has delivered a poor sales growth of 3.00% over past five years.
- Company has a low return on equity of 8.07% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 6 | 4 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 7 | 0 | 3 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 46.92
- Neutral
- MACD (12,26,9)
- −9.30
- Bearish
- SMA (50)
- 680.72
- Bullish
- SMA (200)
- 639.80
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 5Y | +2.99% |
|---|---|
| 3Y | −10.79% |
| 1Y | −14.50% |
| TTM | +17.15% |
Net profit
| 5Y | −32.24% |
|---|---|
| 3Y | −48.53% |
| 1Y | −72.73% |
| TTM | +242.86% |
Operating cash flow
| 5Y | +0.98% |
|---|---|
| 3Y | −5.65% |
| 1Y | Turned positive |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −12.60 pp |
|---|---|
| 3Y | −6.33 pp |
| 1Y | −3.21 pp |
| TTM | +4.18 pp |
Revenue by year
| Mar 2020 | ₹306 Cr |
|---|---|
| Mar 2021 | ₹397 Cr |
| Mar 2022 | ₹643 Cr |
| Mar 2023 | ₹648 Cr |
| Mar 2024 | ₹621 Cr |
| Mar 2025 | ₹538 Cr |
| Mar 2026 | ₹460 Cr |
Net profit by year
| Mar 2020 | ₹35.00 Cr |
|---|---|
| Mar 2021 | ₹42.00 Cr |
| Mar 2022 | ₹68.00 Cr |
| Mar 2023 | ₹44.00 Cr |
| Mar 2024 | ₹40.00 Cr |
| Mar 2025 | ₹22.00 Cr |
| Mar 2026 | ₹6.00 Cr |
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 152 | 148 | 161 | 165 | 139 | 114 | 121 | 131 | 112 | 100 | 117 | 176 | 167 |
| Expenses | 135 | 128 | 142 | 143 | 130 | 106 | 116 | 126 | 107 | 96 | 109 | 158 | 149 |
| Operating Profit | 17 | 20 | 19 | 22 | 9 | 8 | 4 | 5 | 4 | 4 | 8 | 18 | 18 |
| OPM % | 11% | 13% | 12% | 13% | 6% | 7% | 3.7% | 4% | 3.8% | 4.2% | 7% | 10% | 10% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.26 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| PBT | 14 | 17 | 16 | 19 | 5 | 5 | 1 | 2 | 1 | 0 | 5 | 14 | 14 |
| Tax % | 26% | 26% | 26% | 26% | 27% | 25% | 47% | 27% | 35% | −48% | 22% | 27% | 26% |
| Net Profit | 10 | 12 | 12 | 14 | 4 | 4 | 1 | 1 | 1 | 0 | 4 | 10 | 10 |
| EPS (₹) | 7.9 | 9.47 | 9.03 | 10.64 | 3.08 | 2.7 | 0.45 | 0.9 | 0.59 | −0.08 | 2.93 | 7.95 | 8.07 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 306 | 397 | 643 | 648 | 621 | 538 | 460 | 560 |
| Expenses | 258 | 328 | 538 | 576 | 554 | 495 | 438 | 513 |
| Operating Profit | 49 | 69 | 105 | 72 | 67 | 43 | 22 | 48 |
| OPM % | 16% | 17% | 16% | 11% | 11% | 8% | 4.7% | 8% |
| Other Income | 6 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 | 4 | 5 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 | 11 | 11 |
| PBT | 42 | 56 | 91 | 59 | 55 | 30 | 7 | 32 |
| Tax % | 18% | 24% | 26% | 26% | 26% | 27% | 24% | — |
| Net Profit | 35 | 42 | 68 | 44 | 40 | 22 | 6 | 24 |
| EPS (₹) | — | 32.62 | 52.15 | 33.41 | 31.1 | 16.87 | 4.4 | 18.87 |
| Div. Payout % | 0% | 11% | 25% | 22% | 24% | 44% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 127 | 156 | 219 | 246 | 277 | 289 | 250 | 269 |
| Borrowings | 67 | 57 | 62 | 50 | 7 | 63 | 84 | 70 |
| Other Liabilities | 25 | 33 | 30 | 33 | 37 | 37 | 44 | 46 |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 | 391 | 398 |
| Fixed Assets | 126 | 126 | 141 | 156 | 191 | 201 | 196 | 207 |
| CWIP | 9 | 29 | 42 | 35 | 6 | 12 | 18 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 83 | 103 | 141 | 151 | 137 | 189 | 176 | 183 |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 | 391 | 398 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 31 | 40 | 40 | 50 | 74 | −17 | 42 |
| Investing | −24 | −23 | −34 | −14 | −18 | −26 | −14 |
| Financing | −7 | −17 | −6 | −35 | −57 | 42 | −28 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 1 | 17 | 6 | 35 | 57 | −42 | 28 |
| CFO/EBITDA | 82 | 77 | 60 | 88 | 131 | −15 | 180 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 35 | 35 | 33 | 58 | 54 |
| Inventory Days | 65 | 64 | 57 | 61 | 57 | 87 | 96 |
| Days Payable | 12 | 15 | 7 | 8 | 11 | 8 | 12 |
| Cash Conversion Cycle | 98 | 91 | 85 | 89 | 80 | 137 | 139 |
| Working Capital Days | 14 | 43 | 40 | 46 | 63 | 68 | 53 |
| ROCE % | — | 30% | 38% | 22% | 19% | 10% | 3% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fairchem Organics insights
65 extracted metrics across FY12–FY27.
Documents
- Q2 FY27 concall · Oct 2026PPT
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 29 Jun 2026
- 5 Jun 2025
- 4 Jul 2024
- 3 Aug 2023
- 18 Aug 2022
- General announcements 23 Oct 2026
- General announcements 22 Oct 2026
Frequently Asked Questions about Fairchem Organics
What does Fairchem Organics Ltd do?
Where is Fairchem Organics Ltd (FAIRCHEMOR) listed?
Which sector does Fairchem Organics Ltd belong to?
What is the PE ratio of Fairchem Organics Ltd?
What is the 52-week high and low of Fairchem Organics Ltd?
Does Fairchem Organics Ltd pay dividends?
What is the Return on Equity (ROE) of Fairchem Organics Ltd?
Company Information
Fairchem Organics Limited was established in 2019, wherein Fairchem Speciality Limited (FSL) transferred the businesses of Oleo chemicals and nutraceuticals as per the scheme of demerger. Fairchem Organics is engaged in manufacturing of specialty chemicals like dimer acid, linoleic acid, mixed tocopherol concentrate and sterols concentrate, which find application in various industries like nutraceuticals, paints, printing ink, detergents, adhesives, etc.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FAIRCHEMOR.md for Fairchem Organics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.